rs199476128
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP6BS2
The ENST00000361624.2(MT-CO1):c.577G>A(p.Val193Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V193A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000361624.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX1 | COX1.1 use as main transcript | c.577G>A | p.Val193Ile | missense_variant | 1/1 | YP_003024028.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT-CO1 | ENST00000361624.2 | c.577G>A | p.Val193Ile | missense_variant | 1/1 | ENSP00000354499 | P1 |
Frequencies
GnomAD4 exome Cov.: 0
Mitomap
ClinVar
Submissions by phenotype
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1998 | - - |
Mitochondrial disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 18, 2019 | The MT-COX1 m.6480G>A p.(Val193Ile) missense has been identified in individuals with a phenotype consistent with primary mitochondrial disease (Jaksch et al. 1998a; Jaksch et al. 1998b; Puomila et al. 2007; Cai et al. 2008). In several individuals, a second mitochondrial variant was also identified. The variant has also been reported in two of at least 851 controls, including in one individual who was homoplasmic (Jaksch et al. 1998a; Jaksch et al. 1998b; Cai et al. 2008; Dobrowolski et al. 2009; Ray et al. 2009). Based on the available evidence, the m.6480G>A variant is classified as a variant of uncertain significance for primary mitochondrial disease. - |
Leigh syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine | Oct 17, 2019 | The NC_012920.1:m.6480G>A (YP_003024028.1:p.Val193Ile) variant in MTCO1 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BS1, BS4, BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at